Neuromuscular conferences to take place in Canada in 2023
In 2023, several neuromuscular conferences will take place in Canada, hosted by both Canadian and international organizations. These in-person conferences will provide training opportunities, clinical and research updates, and networking opportunities for neuromuscular clinicians and researchers from around the world.
The Canadian Neurological Sciences Federation Congress, the Annual NMD4C Meeting, the Ottawa International Conference on Neuromuscular Disease and Biology, and the World Federation of Neurology’s World Congress of Neurology will all be held in Canada this year.
You can find more information on these events, and other international neuromuscular conferences under the events section of our website.
Canadian Neurological Sciences Federation (CNSF) Congress 2023
Date: June 6 – 9, 2023
Location: Banff, Alberta
Deadlines: Early bird registration: May 4th, 2023
This annual Canadian Congress with four days of accredited scientific courses to assist CNSF members, and others community members with learning and CME opportunities across a variety of neuroscience disciplines.
Neuromuscular-specific sessions at the congress include:
- Jun 6, 8-10:30am | Advances in treatments of hereditary neuromuscular diseases in children and adults
- Jun 6, 5:15-6:45pm | CCS: Neuromuscular Case Discussion
- Jun 7, 8-9:30am Grand Plenary CSCN Gloor Lecture: presented by NMD4C investigator Dr Jodi Warman Chardon
- Jun 8, 12-1:30pm | Lunch ‘n Learn: Measuring outcomes that matter to patients in neuromuscular disease: An individualized approach to transitioning from IVIg to home based therapy with SCIg
Registration is now open, and the congress program is also available.
Annual NMD4C Meeting
Date: September 7th, 2023 (one day before the Ottawa International Conference on Neuromuscular Disease and Biology)
Location: Ottawa, Ontario
This one-day in-person meeting is an opportunity for our network investigators, researchers, clinicians, trainees, and patient partners to foster collaboration, showcase our progress, discuss emerging topics, and set our priorities going forward.
Registration for our annual meeting is now open, and we encourage our members to attend!
6th Ottawa International Conference on Neuromuscular Disease and Biology
Date: September 7-9, 2023
Location: Ottawa, Ontario
Deadlines: Abstract Submission Deadline: June 30th, 2023
The Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023) will feature top international basic and clinical neuromuscular researchers highlighting advances in neuromuscular disease research and clinical care, including novel diagnostic techniques, disease pathogenesis, basic muscle and stem cell biology, and promising therapies to treat these devastating disorders. Sessions will be organized to include basic, translational and clinical presentations to engage all attendees, regardless of background or training.
Registration is now open, and the full program is also available.
World Federation of Neurology’s 26th World Congress of Neurology (WCN 2023)
Date: October 15-19, 2023
Location: Montreal, Quebec
Deadlines: Abstract submission: April 5th, 2023
The WCN 2023 is hosted by the World Federation of Neurology and co-hosted by the Canadian Neurological Sciences Federation (CNSF) for 2023. WCN 2023 provides updates in the broad field of neurology, from tropical neurology to molecular genetics.
Neuromuscular-specific sessions at the congress include:
- Oct 15, 9:15-10:45 am | EMG workshop 1
- Oct 15, 11:15am-12:45pm | EMG workshop 2
- Oct 17, 9-10:30am | Neuromuscular Diseases: WFN, PNS & ICNMD Joint Session: Update On Inflammatory Conditions Of The Peripheral And Central Nervous System (scientific session)
- Oct 17, 9-10:30am | Peripheral neuropathies (teaching course)
- Oct 17, 11am-12:30pm | Neuromuscular diseases: WFN, PNS & ICNMD joint session: Advances in management of acquired and hereditary neuromuscular disorders (scientific session)
- Oct 17, 11am-12:30pm | Neurogenetics (teaching course)
- Oct 17, 11am-12:30pm | Ataxia (scientific session)
- Oct 17, 2:45-4:15pm | Spinal muscular atrophy: from genotype to phenotype and therapy (scientific session)
- Oct 17, 2:45-4:15pm | Update on acquired and hereditary demyelinating neuropathies (scientific session)
- Oct 18, 7- 8:00am | Is it a myopathy? (teaching course)
- Oct 18, 9-10:30am | Neuromuscular disorders part 1 (teaching course)
- Oct 18, 11am-12:30pm | Neuromuscular disorders part 2 (teaching course)
- Oct 19, 9-10:30am | Neuromuscular disease: myasthenia gravis & inflammatory myopathies (scientific session)
- Oct 19, 11-12:30pm | Genetic therapies for hereditary neuromuscular diseases (scientific session)
Registration is now open, and the full scientific program is also available.
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.